series-b
Stage
1
Investors
About
Designs and develops targeted antimicrobials intended to avoid currently known antibiotic resistance mechanisms while sparing non-target bacteria.
Explore Locus Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.